Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tablet 25mg

Clinical trial NCT01819870 · UNKNOWN

Trial details

NCT number: NCT01819870
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Essential Hypertension Chronic Stable Angina Congestive Heart Failure

Start date: 2013-04-01
Primary completion: 2013-05-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.